ClinicalTrials.Veeva

Menu

Fimasartan Blood Pressure Lowering After Acute Stroke (FABULOUS)

B

Boryung

Status

Completed

Conditions

Hypertension
Ischemic Stroke
Transient Ischemic Attack

Study type

Observational

Funder types

Industry

Identifiers

NCT03231293
BR-FMS-OS-401

Details and patient eligibility

About

This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.

Enrollment

1,035 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ischemic stroke or transient ischemic attack occurs after 7 days to 3 months.
  • Mean blood pressure measured 3 times at the first visit (Visit 1) should be over 140 mmHg for systolic blood pressure or 90 mmHg for diastolic blood pressure
  • Suitable for administration of fimasartan
  • The life expectancy should be over 6 months.

Exclusion criteria

  • Patients already treated with antihypertensive medications
  • Hemorrhagic stroke patients

Trial contacts and locations

27

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems